drugset / Trial / NCT00004041
Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
Phase 1
Completed
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Inserting the gene for adenovirus p53 into a person's tumor may improve the body's ability to fight cancer. PURPOSE: Phase I trial to study the effectiveness of gene therapy in treating patients who have recurrent malignant gliomas.
Timeline
- Start
- 1999-02-25
- Primary completion
- 2002-07-22
- Completion
- 2003-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CONTUSUGENE LADENOVEC | Unknown | — | Other |